spacer
home > ebr > Autumn 2004
PUBLICATIONS

European Biopharmaceutical Review

ebr
Autumn 2004
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EBR provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of of biopharmaceuticals, take a look below at the range of articles featured in this issue of EBR.
   
Text
PDF
In her Editor's Letter, Dr Helen Tayton-Martin takes a look at the topics in this issue  
download pdf
Science and Innovation
Dr Majid Mehtali, Vice President of Research & Development at Vivalis SA, underlines the potential of Embryonic Stem Cells: Current and Future Industrial Applications  
download pdf
Unravelling the Mysteries of Alzheimer's - the search for a cure continues, by G Steven Burrill, CEO of Burrill & Company  
download pdf
Sunil Saini, Director of Biomaterials at Therics, maps the development of a new domain in A Perspective in Orthopaedic Tissue Engineering  
download pdf
Hans Herklots, Media and Investor Relations Director at IsoTis OrthoBiologics, looks at the potential transformation of orthopaedics, in Biologics are Entering the Orthopaedic Arena  
download pdf
bullet
Business Development and Financing
How are ideas transformed into a thriving business? Nigel Wild, Managing Director of Oxfordshire BioTechNet Ltd, discusses the options in Funding and Mentoring - The Keys to the Biotech Kingdom  
download pdf
In Technology Transfer from Universities, Tom Hockaday, Executive Director of Isis Innovations Ltd, welcomes the continuing interest in collaboration between academia and the business community  
download pdf
Incubators must form an integral part of our infrastructure for supporting young companies, asserts Toni Wanklin, Development Manager at UK Business Incubation, in Breaking Through The Barrier: How Bio-Incubators Support Tomorrow's World-Class Entrepreneurs  
download pdf
Fiona Brown, Public Relations Consultant, considers today's funding environment and the particular hurdles inherent in biotechnology in Uniting Science and Business: The Challenges for Biotech Start-ups  
download pdf
Science, finance and IPR: conditions for Finnish entrepreneurs uncovered in Challenges for Biotech Start-Ups: A Nordic Perspective, by Professor Kalevi Kairemo, Medical Director and Dr Oula Pe-ate Medina, CEO of CTT Cancer Targeting Technologies  
download pdf
Continuing from Part 1 in our summer issue, Beyond Financial Analysis - Scientific Due Diligence in Pharma and Biotech: Part 2 focuseson clinical trials. By Dr Konrad Burk, Founder of ClinDescience GmbH, William McCulloch, CMO of Gloucester Pharmaceuticals, Dr Alexander von Nieciecki, CEO of BioProof, and Dr Wolfgang Meyer, Senior Director of European Drug Regulatory Affairs and Dr Benno Rattel, Senior Director of Drug Development at GPC Biotech AG  
download pdf
bullet
Legal, Ethical and Regulatory
Valuing Innovation: Patient Access to Novel Therapies, by Alastair Kent, Director of the Genetic Interest Group, explores the disjunction between scientific advances and practical resources  
download pdf
Dr Sarah Rawlings, Policy and Information Officer at Breakthrough Breast Cancer, examines the 'postcode lottery' of UK health care in NICE Implementation - The Patient Perspective  
download pdf
bullet
Biodevelopment and Manufacturing
Dr Stephen Hammond, CEO of Scottish Biomedical, investigates the factors to be weighed in the Successful Outsourcing of Preclinical Drug Discovery  
download pdf
In Electronic Diary Solutions: Enhanced Collection of Patient Reported Outcomes Data, Dr Bill Byrom, Product Development Director at ClinPhone Group Ltd, details alternatives to the traditional paper-based diary that can reduce the likelihood of distorted results  
download pdf
Ivan N Rich, Founder, Chairman and CEO of HemoGenix, Inc, discusses Stem Cell Haemotoxicity Testing to Predict Toxic Side-Effects and as a Tool for Safety Monitoring during Drug Development  
download pdf
Dr Wendy M Shaw, Associate Director (Europe) of the Late Phase Group at Kendle International Inc, explains the function of post-marketing surveillance in recording and studying new adverse drug reactions in Opportunities and Challenges of Pan European Post-Marketing Surveillance Programmes  
download pdf
bullet
Drug Discovery
Identifying Appropriate RNA Interference Drug Candidates opens the door to a whole new class of treatments - by Dr David A Bumcrot, Director, Preclinical at Alnylam Pharmaceuticals, Inc  
download pdf
Angelika Bonin-Debs, Director of Business Development and Strategic Alliances at Xantos Bioscience, charts the advent of RNAi and its role in Loss-of-Function and Gain-of-Function - Two Complementing Genome-Wide Technologies For Drug Discovery and Target Validation  
download pdf
Automation and Robotics in High Throughput Protein Crystallography explained by Bernhard Rupp, Macromolecular Crystallography and Structural Genomics Group of the Lawrence Livermore National Laboratory, University of California  
download pdf
Methods of column protection are presented in Syringe Filter Efficiency and the Effect of Filtration on HPLC Column Life, by Dr Weibing Ding, Senior Staff Scientist and Larry Scheer, Business Development Manager at Pall Corporation  
download pdf
bullet
Regional Focus: Malaysia
Regu Chandar Gnanapragasam, Assistant Manager of the Industrial & Trade Division of the Penang Development Corporation, Simon Saxby, Chief Executive Officer at Alpha Biologics Sdn Bhd and Dr Malcolm Blackwell, Chief Executive Officer at Progenix Research Sdn Bhd, unveil a new development zone for biotech in Malaysian Biotechnology Initiative for the State of Penang  
download pdf
bullet
Regional Focus: Australia
Innovation, investment and government support - Nicola Watkinson, Senior Investment Commissioner, Europe, at Invest Australia, sets the scene in Australian Biotechnology - An Untapped Opportunity  
download pdf
bullet
Preview
CMP Information anticipate this year's BioTech Hot Spot, a unique networking facility at CPhI Worldwide/ICSE  
download pdf
Answering the growing need for partnership opportunities, BIO-Europe 2004: Europe's Largest Partnering Conference, Provides a Platform for Deal-Making and Investors  
download pdf
Tracing global industry trends in Resurgent, Refocused and On the Threshold - Insights from Ernst & Young's 11th Annual Global Biotechnology Report, by EBR Editor Helen Tayton-Martin  
download pdf
Advokat Lars Rambe, Head of Life Science at Adokatfirman Delphi & Co, compares IP systems in the EU and US in Commercialisation of Inventions from Scandinavian Universities - A Challenge and an Opportunity  
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

Sartorius debuts the Intellicyt iQue3 at CYTO® 2019

Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3. The event – which takes place in Vancouver, Canada, from June 22 to 26 – will give delegates the chance to explore a smarter way to perform flow cytometry experiments.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement